Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Apicoplast DNA polymerase (apPol) is the essential enzyme responsible for the replication and repair of the 35-kb circular genome found within the apicoplast of Plasmodium parasites. The apicoplast is a vestigial, non-photosynthetic plastid derived from an ancient endosymbiotic event, and it is vital for the parasite’s survival, primarily as the site of isoprenoid precursor biosynthesis. In species like Plasmodium falciparum, the polymerase is often encoded as part of a multifunctional polyprotein called Pfprex (Plastid replication-repair enzyme), which contains primase, helicase, and polymerase domains. As an A-family DNA polymerase with prokaryotic lineage, apPol is structurally distinct from human nuclear and mitochondrial polymerases, providing a unique opportunity for highly selective antimalarial drug development. Inhibition of apicoplast DNA synthesis—whether by targeting apPol directly or associated proteins like DNA gyrase—typically results in a characteristic 'delayed death' phenotype. This phenomenon involves the parasite surviving the initial drug exposure but failing to survive in the subsequent generation due to the loss of functional apicoplasts in daughter cells. This target is particularly valued for its potential to combat multidrug-resistant malaria when used in combination therapies.
Inhibition of DNA synthesis within the apicoplast prevents the replication and inheritance of the organelle's genome, leading to the loss of the essential apicoplast and subsequent parasite death, typically manifesting as a 'delayed death' phenotype.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Apicoplast DNA polymerase (apPol) (apPol).